3.Experimental study of arsenic trioxide on rabbits with hepatic Vx-2 carcinoma by transcatheter arterial infusion
Journal of Third Military Medical University 2003;0(16):-
Objective To evaluate the anticancer effect of arsenic trioxide (As 2O 3) on rabbits with hepatic Vx 2 carcinoma by transcatheter arterial infusion (TAI). Methods Rabbits with hepatic Vx 2 carcinoma were treated with As 2O 3 by TAI for 7 d consecutively. The tumor inhibitory rate and the average tumor weight were determined. The morphological changes of the tumor were observed with a transmission electron microscope. bax/bcl 2 and VEGF expressions were examined by immunohistochemistry. Results The average weight of the tumor was 7.99, 6.50, and 4.87 g, and the tumor growth inhibitory rates in the experimental groups were 50.31%, 59 58%, and 69 71%, respectively. Tumor growth was significantly inhibited as compared with that in the NS group ( P
4.The research status of preclinical animal experiments of gene therapy for Leber congenital amaurosis
Chinese Journal of Experimental Ophthalmology 2014;32(8):764-768
Leber congenital amaurosis (LCA) is extremely severe hereditary retinal dystrophy,because it leads to congenital bilateral blindness in early childhood.With the development of molecular genetics and the therapeutic gene replacement technology,gene therapy clinical trials have obtained exciting results on the basis of relatively satisfied with preliminary clinical experimental results by adeno-associated virus (AAV) vector-mediated gene therapy in the past decade.These researching methods include intravitreal injection and subretinal space injection of gene vector,and the investigating indexes include evaluations of visual function and safety,such as immune reaction of the animals,ocular histopathological change,complications and bio-distribution of gene sequence.The preliminary success of the LCAⅡ Ⅱ gene therapy will give some clues to the other inherited retinal diseases.This review focuses on the present status of pre-clinical animal experiments of its gene therapy.
6.The portable low power military ECG for triage
Chinese Medical Equipment Journal 2004;0(09):-
The military portable ECG for triage is a kind of minitype monitoring equipment for life information for the purpose that the ambulanceman carry through first aids in frontline. Life information of the wounded will be acquired exactly and quickly applying with this equipment, then quickening the triage and reducing the casualties. The system is based on C8051F310 single chip microcomputer, applying with high accuracy, low offset drift instrumentation amplifier AD620 and ultra low power LCM LMS019 to display real-time and accurate ECG signal sampled. The equipment is easy to use and inexpensive, suitable for mass requirement of our field army.
7.Physical Examination and Laboratory Diagnosis Before Operation of Anorectal Diseases Concerned with Occupational Harm
Chinese Journal of Nosocomiology 2009;0(24):-
OBJECTIVE To discuss the necessity of physical examination and laboratory diagnosis before operation of patients with anorectal diseases,and analyze the occupational harm of the staff.METHODS The results of physical examination and laboratory diagnosis before operation in 320 cases were reviewed,and summerized the various kinds of infectious diseases.RESULTS Forty-eight(15.00%) cases accompanied with variety classes of infectious diseases,and 39(12.19%)cases of them accompanied with transfusion-transmitted disease.CONCLUSIONS It is important to think highly of the current situation of anorectal diseases accompanied with infectious diseases,evaluate reasonably the occupational diagnosis to avoid occupational harm.
8.Preoperative and postoperative prognostic indicators of recurrence of hepatocellular carcinoma following liver transplantation
International Journal of Surgery 2010;37(8):557-561
Liver transplantation is a valid treatment option for select patients with Hepatocellular Carcinoma HCC and end-stage liver disease. However, in approximately 20% of patients, recurrent HCC is the rate-limiting factor for longterm survival. Despite identification of clinical parameters that may stratify patients at high risk and exhaustive preoperative staging, cancer recurrence is likely the result of microscopic extrahepatic disease. With a desperate donor organ shortage, locoregional ablation techniques and resection are being employed in patients on the waiting list to serve as a bridge to OLT. Further more, some have advocated aggressive surgical resection of isolated metastasis in both the liver and extrahepatic viscera. Whether these creative strategies confer a survival advantage is unknown, requiring longterm follow-up to determine their efficacy.
9.Advance of mini-invasive treatments of hepatic portal hypertension in cirrhosis
Journal of Medical Postgraduates 2003;0(05):-
The therapeutic management of hepatic portal hypertension in patients with cirrhosis is still a challenge. At present surgical devascularization and shunting play the important roles in treatment of portal hypertension. While some cirrhotic patients can not bear the stress of operation and anesthesia because of inadequat potential hepatic function. So the mortality of operation is very high. With the development of endoscopy,radiological techniques and new materials and equipments, the mini invasive treatments become more important. This review summarizes the current advances of mini invasive treatments of portal hypertension in cirrhosis.
10.Pharmaceutical Care of Hypoglycemic Regimen for A Patient with Insulin Resistant
Herald of Medicine 2017;36(1):99-101
Objective To summarize the method and experience of pharmaceutical care for a patient with insulin resistant. Methods The rationality of the treatment plan was analyzed by the clinical pharmacist, and the entire pharmaceutical care process was implemented to the patient. Results Doctors took the advice of clinical pharmacists, perfected the treatment plan. The treatment was safe and effective. The patient was discharged with a better health condition. Conclusion Clinical pharmacist integrates in the treatment team,and to promote the rational use of drugs.